Log in
NYSE:CGC

Canopy Growth Stock Forecast, Price & News

Trending Stocks  
$19.73
-0.57 (-2.81 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$19.53
Now: $19.73▼
$20.44
50-Day Range
$14.05
MA: $16.37▼
$20.30
52-Week Range
$9.00
Now: $19.73▼
$25.97
Volume5.11 million shs
Average Volume6.27 million shs
Market Capitalization$7.34 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.39
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Read More
Canopy Growth logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.1Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.26 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Medicinals & botanicals
Sub-IndustryCannabis
SectorMedical
Current SymbolNYSE:CGC
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.canopygrowth.com
Phone855-558-9333
Employees4,434

Debt

Debt-to-Equity Ratio0.09
Current Ratio8.18
Quick Ratio6.96

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$297.34 million
Price / Sales24.67
Cash Flow$1.57 per share
Price / Cash Flow12.55
Book Value$10.98 per share
Price / Book1.80

Profitability

EPS (Most Recent Fiscal Year)$1.32
Net Income$-993,370,000.00
Net Margins-439.18%
Return on Equity-21.30%
Return on Assets-15.22%

Miscellaneous

Outstanding Shares371,789,000
Market Cap$7.34 billion
Next Earnings Date11/12/2020 (Estimated)
OptionableOptionable
$19.73
-0.57 (-2.81 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CGC News and Ratings via Email

Sign-up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Canopy Growth (NYSE:CGC) Frequently Asked Questions

How has Canopy Growth's stock price been impacted by Coronavirus (COVID-19)?

Canopy Growth's stock was trading at $13.35 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CGC stock has increased by 47.8% and is now trading at $19.73.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Canopy Growth?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 3 sell ratings, 12 hold ratings, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Canopy Growth.

When is Canopy Growth's next earnings date?

Canopy Growth is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Canopy Growth.

How were Canopy Growth's earnings last quarter?

Canopy Growth Corp (NYSE:CGC) released its quarterly earnings results on Monday, August, 10th. The marijuana producer reported ($0.20) EPS for the quarter, beating analysts' consensus estimates of ($0.28) by $0.08. The marijuana producer had revenue of $85.91 million for the quarter, compared to the consensus estimate of $73.71 million. Canopy Growth had a negative net margin of 439.18% and a negative return on equity of 21.30%.
View Canopy Growth's earnings history.

What price target have analysts set for CGC?

19 brokers have issued 1-year price targets for Canopy Growth's stock. Their forecasts range from $15.60 to $40.00. On average, they expect Canopy Growth's share price to reach $28.12 in the next year. This suggests a possible upside of 42.5% from the stock's current price.
View analysts' price targets for Canopy Growth.

Who are some of Canopy Growth's key competitors?

Some companies that are related to Canopy Growth include Canopy Growth (WEED), Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), OrganiGram (OGI), Emblem (EMC), ICC Labs (ICC), Bioventix (BVXP), 22nd Century Group (XXII), KushCo (KSHB), General Cannabis (CANN), Grow Capital (GRWC), Terra Tech (TRTC), Leafbuyer Technologies (LBUY), Nemus Bioscience (NMUS) and Mentor Capital (MNTR).
View all competitors.

What other stocks do shareholders of Canopy Growth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Canopy Growth investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), General Electric (GE), Aurora Cannabis (ACB), Cronos Group (CRON), Canopy Growth (WEED), Tilray (TLRY), KushCo (KSHB) and Advanced Micro Devices (AMD).

Who are Canopy Growth's key executives?

Canopy Growth's management team includes the following people:
  • Mr. Bruce A. Linton, Co-Founder, Chairman & Co-CEO (Age 52)
  • Mr. Mark Anthony Nicholas Zekulin, Pres & Co-CEO
  • Mr. Timothy Rob Saunders, Exec. Officer
  • Mr. Rade Kovacevic, Exec. VP
  • Mr. Mike Lee, Acting Chief Financial Officer

What is Canopy Growth's stock symbol?

Canopy Growth trades on the New York Stock Exchange (NYSE) under the ticker symbol "CGC."

Who are Canopy Growth's major shareholders?

Canopy Growth's stock is owned by a variety of institutional and retail investors. Top institutional investors include Hamilton Wealth LLC (0.03%), Riggs Asset Managment Co. Inc. (0.02%), Capstone Financial Group Inc. (0.02%), Ingalls & Snyder LLC (0.01%), Wedbush Securities Inc. (0.01%) and Boyd Watterson Asset Management LLC OH (0.01%).

Which major investors are selling Canopy Growth stock?

CGC stock was sold by a variety of institutional investors in the last quarter, including Wedbush Securities Inc., Flagship Harbor Advisors LLC, Resources Investment Advisors LLC., CWM LLC, Pinnacle Associates Ltd., Ingalls & Snyder LLC, and TRUE Private Wealth Advisors.

Which major investors are buying Canopy Growth stock?

CGC stock was acquired by a variety of institutional investors in the last quarter, including Riggs Asset Managment Co. Inc., Boyd Watterson Asset Management LLC OH, NuWave Investment Management LLC, Capstone Financial Group Inc., Hamilton Wealth LLC, NEXT Financial Group Inc, and Westside Investment Management Inc..

How do I buy shares of Canopy Growth?

Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Canopy Growth's stock price today?

One share of CGC stock can currently be purchased for approximately $19.73.

How big of a company is Canopy Growth?

Canopy Growth has a market capitalization of $7.34 billion and generates $297.34 million in revenue each year. The marijuana producer earns $-993,370,000.00 in net income (profit) each year or $1.32 on an earnings per share basis. Canopy Growth employs 4,434 workers across the globe.

What is Canopy Growth's official website?

The official website for Canopy Growth is www.canopygrowth.com.

How can I contact Canopy Growth?

Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The marijuana producer can be reached via phone at 855-558-9333 or via email at [email protected]

This page was last updated on 10/24/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.